SSSW(SH:688399) Jing Ji Guan Cha Wang·2025-09-14 03:26Core Viewpoint - The sudden passing of Liu Zhonghua, a core founder and key executive of Shuoshi Biotechnology, raises concerns about the company's future amidst industry challenges and operational pressures [2][5][6] Company Overview - Shuoshi Biotechnology was founded in 2010, focusing on infectious disease testing and maternal and child health [5] - The company specializes in the research, production, and sales of in vitro diagnostic reagents and related testing instruments, adopting an integrated business model of "reagents + instruments + services" [5] Leadership and Contributions - Liu Zhonghua was a molecular biology expert and had a significant role in the company's development, serving as a technical director and vice president from 2010 to 2017, and as a board member since 2017 [5][6] - He voluntarily reduced his salary by 40% recently to support the company's operational efficiency [6] - Liu held 2.57% of the company's total shares, amounting to 2.15 million shares [5] Recent Company Performance - Shuoshi Biotechnology is currently facing performance pressures due to industry adjustments [6] - The company recently implemented voluntary salary reductions among its executives to optimize operational costs and improve management efficiency [6] Board Composition - Following Liu Zhonghua's passing, the board of directors has decreased from 9 to 8 members, which is still above the legal minimum but below the number stipulated in the company's articles of association [6] - The company plans to complete the board member replacement process in accordance with legal procedures [6]